金城医药：全资子公司收到化学原料药上市申请批准通知书

Group 1 - The core point of the article is that Jincheng Pharmaceutical (300233) announced the approval of a chemical raw material drug listing application by the National Medical Products Administration [1] Group 2 - The approval notification was issued to Jincheng Pharmaceutical's wholly-owned subsidiary, Beijing Jincheng Tail Pharmaceutical Co., Ltd. [1]